tetano
Editor, Senior Moderator
HeartRhythm Case Rep. 2020 Apr 1. doi: 10.1016/j.hrcr.2020.03.016. [Epub ahead of print]
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.
Mitra RL[SUP]1[/SUP], Greenstein SA[SUP]1[/SUP], Epstein LM[SUP]1[/SUP].
Author information
KEYWORDS:
Acquired LQTS; Azithromycin; COVID-19; Chloroquine; Drug toxicity; Flow chart; Hydroxychloroquine; Long QT; Pandemic; Proarrhythmia; Torsades de pointes; Ventricular fibrillation
PMID:32363145PMCID:PMC7195299DOI:10.1016/j.hrcr.2020.03.016
Free full text
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine.
Mitra RL[SUP]1[/SUP], Greenstein SA[SUP]1[/SUP], Epstein LM[SUP]1[/SUP].
Author information
KEYWORDS:
Acquired LQTS; Azithromycin; COVID-19; Chloroquine; Drug toxicity; Flow chart; Hydroxychloroquine; Long QT; Pandemic; Proarrhythmia; Torsades de pointes; Ventricular fibrillation
PMID:32363145PMCID:PMC7195299DOI:10.1016/j.hrcr.2020.03.016
Free full text